Data is not available at this time.
Nitto Denko Corporation is a leading Japanese specialty chemicals company with a diversified portfolio centered on adhesive tapes, functional films, and advanced materials. The company operates across multiple high-growth industries, including automotive, electronics, medical, and construction, leveraging its expertise in polymer science to deliver precision-engineered solutions. Its core revenue model is built on manufacturing and selling high-performance adhesive products, flexible printed circuit boards, and specialty films, which are critical components in modern industrial and consumer applications. Nitto Denko holds a strong market position due to its technological leadership, extensive R&D capabilities, and long-standing relationships with global OEMs. The company’s focus on innovation, particularly in semiconductor manufacturing and medical adhesives, reinforces its competitive edge in niche markets. With a broad geographic footprint and a reputation for reliability, Nitto Denko is well-positioned to capitalize on trends like electrification, miniaturization in electronics, and advancements in medical wearable technologies.
Nitto Denko reported revenue of JPY 1,013.9 billion for FY2025, with net income of JPY 137.2 billion, reflecting a net margin of approximately 13.5%. The company’s operating cash flow stood at JPY 217.9 billion, demonstrating strong cash generation capabilities. Capital expenditures of JPY 106.0 billion indicate ongoing investments in production capacity and R&D, aligning with its growth strategy in high-value segments.
The company’s diluted EPS of JPY 195.67 underscores its earnings strength, supported by a disciplined cost structure and premium product mix. Nitto Denko’s capital efficiency is evident in its ability to maintain profitability while investing in innovation, with a balanced approach to reinvestment and shareholder returns. Its low beta of 0.569 suggests stable earnings relative to market volatility.
Nitto Denko maintains a robust balance sheet, with JPY 363.3 billion in cash and equivalents and minimal total debt of JPY 455 million. This conservative leverage profile provides ample liquidity for strategic initiatives and mitigates financial risk. The company’s strong cash position supports its ability to navigate cyclical demand fluctuations in its end markets.
Growth is driven by demand for advanced materials in electronics and automotive applications, alongside expansion in medical adhesives. The company’s dividend per share of JPY 60 reflects a commitment to returning capital to shareholders, though its payout ratio remains moderate, allowing reinvestment in high-return projects. Future growth may hinge on scaling innovations in semiconductor and display technologies.
With a market cap of JPY 1,827.7 billion, Nitto Denko trades at a premium reflective of its niche leadership and stable cash flows. Investors likely value its defensive positioning in specialty chemicals and exposure to secular growth trends in electronics and healthcare. The low beta further signals its resilience as a lower-risk industrial holding.
Nitto Denko’s strategic advantages lie in its deep material science expertise, diversified end-market exposure, and strong R&D pipeline. The outlook remains positive, supported by demand for high-performance adhesives in electric vehicles and wearable medical devices. However, macroeconomic headwinds and raw material cost volatility could pose near-term challenges, requiring continued operational agility.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |